These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11327446)

  • 1. Influence of time and storage conditions on plasma HIV viral load measurements.
    Holguín A; Williams L; Castilla J; Soriano V
    Antivir Ther; 1997 Dec; 2(4):265-8. PubMed ID: 11327446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of HIV RNA in plasma specimens stored at different temperatures.
    Amellal B; Murphy R; Maiga A; Brucker G; Katlama C; Calvez V; Marcelin AG
    HIV Med; 2008 Oct; 9(9):790-3. PubMed ID: 18754803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient viremia in HIV-infected patients and use of plasma preparation tubes.
    Stosor V; Palella FJ; Berzins B; Till M; Leake A; Chmiel JS; Murphy RL
    Clin Infect Dis; 2005 Dec; 41(11):1671-4. PubMed ID: 16267742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens.
    Marconi A; Balestrieri M; Comastri G; Pulvirenti FR; Gennari W; Tagliazucchi S; Pecorari M; Borghi V; Marri D; Zazzi M
    Clin Microbiol Infect; 2009 Jan; 15(1):93-7. PubMed ID: 19220340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA.
    Elbeik T; Nassos P; Kipnis P; Haller B; Ng VL
    J Clin Microbiol; 2005 Aug; 43(8):3769-71. PubMed ID: 16081908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0.
    van Deursen P; Oosterlaken T; Andre P; Verhoeven A; Bertens L; Trabaud MA; Ligeon V; de Jong J
    J Clin Virol; 2010 Feb; 47(2):120-5. PubMed ID: 20018560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification.
    Amellal B; Katlama C; Calvez V
    HIV Med; 2007 Sep; 8(6):396-400. PubMed ID: 17661848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0.
    Kellogg JA; Atria PV; Sanders JC; Eyster ME
    Clin Diagn Lab Immunol; 2001 May; 8(3):560-3. PubMed ID: 11329458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients.
    Gottesman BS; Grossman Z; Lorber M; Levi I; Shitrit P; Katzir M; Shahar E; Gottesman G; Chowers M
    J Med Virol; 2006 Jul; 78(7):883-7. PubMed ID: 16721845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.
    Kane CT; Ndiaye HD; Diallo S; Ndiaye I; Wade AS; Diaw PA; Gaye-Diallo A; Mboup S
    J Virol Methods; 2008 Mar; 148(1-2):291-5. PubMed ID: 18242718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT).
    Griffith BP; Mayo DR
    J Clin Virol; 2006 Feb; 35(2):197-200. PubMed ID: 16253548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.